Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1.

Diversity and dialogue in immunity to helminths. Nat Rev Immunol (2011) 3.72

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88

Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol (2012) 1.48

Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev (2011) 1.45

Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci U S A (1999) 1.42

Eosinophils in innate immunity: an evolving story. Cell Tissue Res (2010) 1.34

Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest (1993) 1.23

Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J (1994) 1.11

Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol (2014) 1.08

Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster. Am J Pathol (1993) 1.08

Eosinophils and disease pathogenesis. Semin Hematol (2012) 1.05

Orbital involvement in multifocal fibrosclerosis. Br J Ophthalmol (1995) 0.99

Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med (1994) 0.95

Shared signaling systems in myeloid cell-mediated muscle regeneration. Development (2014) 0.95

Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis. World J Gastroenterol (2009) 0.93

Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer (2004) 0.92

Eosinophilic cholangitis and cholangiopathy: a sheep in wolves clothing. HPB Surg (2010) 0.91

Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy (2014) 0.91

Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am J Pathol (1993) 0.90

Spectrum of Eosinophilic End-Organ Manifestations. Immunol Allergy Clin North Am (2015) 0.89

Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways. Front Immunol (2012) 0.84

Eosinophilic Cholangitis-A Challenging Diagnosis of Benign Biliary Stricture: A Case Report. Medicine (Baltimore) (2016) 0.79

Th2 cells and cytokine networks in allergic inflammation of the lung. Mediators Inflamm (1995) 0.75

The Biology of Eosinophils and Their Role in Asthma. Front Med (Lausanne) (2017) 0.75

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (1983) 15.43

A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci U S A (1984) 8.67

Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol (1982) 5.44

A comparative study on the genes for three porins of the Escherichia coli outer membrane. DNA sequence of the osmoregulated ompC gene. J Biol Chem (1983) 4.42

Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature (1990) 4.21

Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol (2000) 4.12

Osmoregulation of gene expression. I. DNA sequence of the ompR gene of the ompB operon of Escherichia coli and characterization of its gene product. J Biol Chem (1982) 3.89

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89

Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature (1981) 3.71

Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med (1985) 3.69

Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med (1989) 3.03

Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82

Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) (1988) 2.64

IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med (1997) 2.48

Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med (2000) 2.46

Mast cells as a source of multifunctional cytokines. Immunol Today (1990) 2.46

Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci U S A (1991) 2.41

Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest (1997) 2.29

Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23

Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ (1990) 2.22

Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med (1991) 2.21

Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A (1991) 2.17

Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol (1979) 2.15

Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest (1991) 2.14

Regulation of mast cell survival by IgE. Immunity (2001) 2.11

Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Rheumatology (Oxford) (2005) 2.11

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat Immunol (2001) 2.10

Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol (1987) 2.05

Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04

Identification of a committed precursor for the mast cell lineage. Science (1996) 2.04

Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol (2000) 2.02

The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01

Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00

Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med (1998) 1.99

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97

Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A (1987) 1.96

The efficacy of a semirigid ankle stabilizer to reduce acute ankle injuries in basketball. A randomized clinical study at West Point. Am J Sports Med (1994) 1.94

Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy (1984) 1.94

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A (1983) 1.91

Bronchoconstrictor effects of leukotriene C in humans. Science (1982) 1.91

Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol (1982) 1.91

Quantum confinement and electronic properties of silicon nanowires. Phys Rev Lett (2004) 1.91

The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med (1991) 1.89

Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85

Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med (1998) 1.84

Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78

A longitudinal analysis of unaided smoking cessation. J Consult Clin Psychol (1988) 1.78

The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol (2000) 1.76

Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology (1996) 1.75

Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med (1979) 1.74

The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol (1992) 1.72

Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol (1988) 1.67

Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A (1991) 1.67

Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest (1997) 1.67

Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol (1993) 1.65

Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65

Eosinophilia. J Allergy Clin Immunol (1984) 1.65

Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am (1993) 1.63

Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg (1984) 1.63

Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J Clin Invest (1989) 1.62

Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A (1989) 1.62

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58

125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol (1987) 1.58

Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57

Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol (1993) 1.57

Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect Immun (1991) 1.55

IL-4 directly modulates function of a model human intestinal epithelium. J Immunol (1994) 1.53

The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol (1994) 1.53

Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science (1984) 1.53

Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49

Ultrastructural identification of the mouse basophil. Blood (1982) 1.47

Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest (1989) 1.47

The basal lamina of the postnatal mammary epithelium contains glycosaminoglycans in a precise ultrastructural organization. Dev Biol (1980) 1.45

Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol (1997) 1.45

IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol (1999) 1.45

Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol (1982) 1.45

Induction of intra-articular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine Vet J (1995) 1.45

Thermal stability and electronic structure of atomically uniform Pb films on Si(111). Phys Rev Lett (2004) 1.44

Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice. Blood (1987) 1.43

Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J Clin Invest (1993) 1.43

Abstinence violation effect: validation of an attributional construct with smoking cessation. J Consult Clin Psychol (1987) 1.43

Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res (1999) 1.40

Use of postauricular skin grafts for vestibular reconstruction. J Oral Maxillofac Surg (1992) 1.39

Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol (1993) 1.38

Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis (1991) 1.38

IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol (1997) 1.38

Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc (1995) 1.38

Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol (1986) 1.37

The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36

Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem (1992) 1.35

The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function. J Exp Med (1992) 1.35